ICON’s Pricing and Market Access team ... will have special focuses on disruptive technologies in pharma, R&D innovation, market access and commercialisation, oncology, sales & marketing ...
Gone are the days when pharma companies could charge ... following in the footsteps of rival CRO, ICON plc, which acquired value strategy market access consultancy PriceSpective in early 2012.
Agreement drives continued patient access to four important therapies in Japan and KoreaStrengthens Essential Pharma and Clinigen’s combined ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback